Abstract
Background: Adult T-cell leukemia (ATL) is an acute malignancy of activated T-cells caused by the human T-cell lymphotrophic virus type-1 (HTLV-1). Materials and Methods: The effects of non-cytotoxic concentrations of ascorbic acid (AA) were evaluated against HTLV-1 positive and negative cells. The effect of AA on apoptosis and proliferation was evaluated by cell cycle analysis. The role of p53, p21 Bax and Bcl-2α on cell cycle modulation and apoptosis was also assessed. The anti-proliferative effects were tested by determining the changes in the expression of transforming growth factors (TGF-α, TGF-β1 and TGF-β2). Results: Ascorbic acid was found to reduce the proliferation of cells and induce apoptosis by the modulation of p53, p21, Bcl-2 and Bax. Conclusion: The results of this study show the anti-proliferative effects of AA against leukemic cells.
ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Bazarbachi A, 1996, J ACQ IMMUN DEF SYND, V13, pS186, DOI 10.1097-00042560-199600001-00028; BISSELL MJ, 1980, P NATL ACAD SCI-BIOL, V77, P2711, DOI 10.1073-pnas.77.5.2711; BLAKESLEE JR, 1985, CANCER RES, V45, P3471; Cameron E., 1979, CANC VITAMIN C, P132; CAMERON E, 1973, ONCOLOGY-BASEL, V27, P181; Carlisle DL, 2000, TOXICOL SCI, V55, P60, DOI 10.1093-toxsci-55.1.60; Carr A, 1999, FASEB J, V13, P1007; Casciari JJ, 2001, BRIT J CANCER, V84, P1544, DOI 10.1054-bjoc.2001.1814; Douglas RM, 1998, COCHRANE DB SYST REV, DOI [10.1002-14651858.CD000980, DOI 10.1002-14651858.CD000980]; Dunker N, 2002, GASTROENTEROLOGY, V122, P1364, DOI 10.1053-gast.2002.32991; El-Sabban ME, 2000, BLOOD, V96, P2849; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002-1097-0142(196504)18:4522::AID-CNCR28201804183.0.CO;2-J; Gackowski D, 2002, INT J CANCER, V101, P395, DOI 10.1002-ijc.10610; Groninger E, 2002, INT J ONCOL, V21, P1339; Harakeh S, 2004, CHEM-BIOL INTERACT, V148, P101, DOI 10.1016-j.cbi.2004.05.002; Harakeh S, 1995, NUTRITION, V11, P684; HARAKEH S, 1990, P NATL ACAD SCI USA, V87, P7245, DOI 10.1073-pnas.87.18.7245; Harakeh S, 1997, AIDS RES HUM RETROV, V13, P235, DOI 10.1089-aid.1997.13.235; HARAKEH S, 1994, CHEM-BIOL INTERACT, V91, P207, DOI 10.1016-0009-2797(94)90041-8; HARAKEH S, 1991, AM J CLIN NUTR, V54, pS1231; Harakeh Steve, 1994, Journal of Nutritional Medicine, V4, P393, DOI 10.3109-13590849409003588; Jamison JM, 2004, BIOCHEM PHARMACOL, V67, P337, DOI 10.1016-j.bcp.2003.08.040; Kanai M, 2001, GASTROENTEROLOGY, V121, P56, DOI 10.1053-gast.2001.25544; KAZAKOV SA, 1988, NATURE, V335, P186, DOI 10.1038-335186a0; LIEHR JG, 1991, AM J CLIN NUTR, V54, pS1256; Martin A, 1997, ARTERIOSCL THROM VAS, V17, P1583; MEDINA MA, 1994, BIOCHEM MOL BIOL INT, V34, P871; MORTENSEON MM, 1986, J SURG RES, V114, P302; MURATA A, 1976, J NUTR SCI VITAMINOL, V22, P347; MURATA A, 1973, AGR BIOL CHEM TOKYO, V37, P1145; NAIDU A.K., 2003, NUTR J, V2, P7; PAGANELLI GM, 1992, J NATL CANCER I, V84, P47, DOI 10.1093-jnci-84.1.47; PAVELIC K, 1985, BRAIN RES, V342, P369, DOI 10.1016-0006-8993(85)91139-4; Reddy VG, 2001, BIOCHEM BIOPH RES CO, V282, P409, DOI 10.1006-bbrc.2001.4593; SCHWARZ RI, 1991, AM J CLIN NUTR, V54, pS1247; Van Orden K, 1999, J BIOL CHEM, V274, P26321, DOI 10.1074-jbc.274.37.26321; WAHL SM, 1992, J CLIN IMMUNOL, V12, P61, DOI 10.1007-BF00918135; Wang DG, 2002, ONCOGENE, V21, P2785, DOI 10.1038-sj-onc-1205375